Literature DB >> 12796825

Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population.

Carla Teixeira1, António Guimarães, Carlos Bessa, Maria José Ferreira, Lurdes Lopes, Eugénia Pinto, Rui Pinto, Rose-Mary Boustany, Maria Clara Sá Miranda, Maria Gil Ribeiro.   

Abstract

A series of 53 Portuguese patients (derived from 43 families) born in the period 1963-1999 have been diagnosed with neuronal ceroid lipofuscinosis (NCL) based on clinicopathological findings. Plotting the cumulative number of new cases per year against the year of birth resulted in a slightly S-shaped curve, with a nearly straight central segment over a period of 14 years (1977-1990) indicating a continuous registration of new cases born during the corresponding time period. In this period the prevalence of overall NCL in the Portuguese population was calculated to be 1.55 per 100.000 live births.Twenty-six patients from 20 unrelated families were further evaluated by combining clinicopathological with biochemical and genetic data. No intra-familial heterogeneity was observed. Four sub-types of childhood NCL were identified: infantile NCL (INCL) with granular osmiophilic inclusions (GROD) and PPT1 deficiency (1/26), classical LINCL with curvilinear (CV) inclusions and tripeptidyl peptidase (TPP1) deficiency (3/26), variant late infantile NCL (LINCL) with fingerprint/curvilinear (FP/CV) inclusions and normal TPP1 enzyme activity (11/26) and juvenile NCL (JNCL) with a mix of FP/CV (11/26). Eight of 11 JNCL patients were homozygous for the 1.02-kb deletion in the CLN3 gene, and 3 were heterozygous with an unidentified mutation in the second allele. The 1.02-kb deletion in the CLN3 gene accounted for 86.3 % (19/22) of CLN3-causing alleles and 36.5 % (19/52) of childhood NCL defects. The causal mutations for CLN1 and CLN2 were V181M (2/2) and R208X (4/6), respectively. CLN1, CLN2 and CLN3 affected 3.8 %, 11.5 % and 42.3 % of NCL Portuguese patients, respectively. In 42.3 % of patients affected by the vLINCL form, CLN3, CLN5 and CLN8 gene defects were excluded by direct sequencing of cDNA. Genetic variants such as CLN6 might therefore cause a significant portion of childhood NCL in the Portuguese population. The relative frequency of classical childhood forms of NCL in the Portuguese population is reported and contributes to the knowledge of genetic epidemiology of these world-widely distributed disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796825     DOI: 10.1007/s00415-003-1050-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  8 in total

Review 1.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

2.  Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: Another genetic hit in the Mediterranean.

Authors:  Natalia Cannelli; Denise Cassandrini; Enrico Bertini; Pasquale Striano; Lucia Fusco; Roberto Gaggero; Nicola Specchio; Roberta Biancheri; Federico Vigevano; Claudio Bruno; Alessandro Simonati; Federico Zara; Filippo M Santorelli
Journal:  Neurogenetics       Date:  2006-03-29       Impact factor: 2.660

3.  Analysis of large-scale whole exome sequencing data to determine the prevalence of genetically-distinct forms of neuronal ceroid lipofuscinosis.

Authors:  David E Sleat; Erika Gedvilaite; Yeting Zhang; Peter Lobel; Jinchuan Xing
Journal:  Gene       Date:  2016-08-20       Impact factor: 3.688

4.  CLN6 p.I154del mutation causing late infantile neuronal ceroid lipofuscinosis in a large consanguineous Moroccan family.

Authors:  Ahmed Bouhouche; Wafae Regragui; Elmostafa El Fahime; Naima Bouslam; Rachid Tazi-Ahnini; Marouane Melloul; Ali Benomar; Mohamed Yahyaoui
Journal:  Indian J Pediatr       Date:  2012-11-22       Impact factor: 1.967

5.  Cerliponase Alfa for the Treatment of Atypical Phenotypes of CLN2 Disease: A Retrospective Case Series.

Authors:  Eva Wibbeler; Raymond Wang; Emily de Los Reyes; Nicola Specchio; Paul Gissen; Norberto Guelbert; Miriam Nickel; Christoph Schwering; Lenora Lehwald; Marina Trivisano; Laura Lee; Gianni Amato; Jessica Cohen-Pfeffer; Renée Shediac; Fernanda Leal-Pardinas; Angela Schulz
Journal:  J Child Neurol       Date:  2020-12-23       Impact factor: 1.987

6.  A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease.

Authors:  Jeremy P Morgan; Helen Magee; Andrew Wong; Tarah Nelson; Bettina Koch; Jonathan D Cooper; Jill M Weimer
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

Review 7.  The CLN3 gene and protein: What we know.

Authors:  Myriam Mirza; Anna Vainshtein; Alberto DiRonza; Uma Chandrachud; Luke J Haslett; Michela Palmieri; Stephan Storch; Janos Groh; Niv Dobzinski; Gennaro Napolitano; Carolin Schmidtke; Danielle M Kerkovich
Journal:  Mol Genet Genomic Med       Date:  2019-09-30       Impact factor: 2.183

8.  Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers.

Authors:  Anastasiya A Kozina; Elena G Okuneva; Natalia V Baryshnikova; Olga B Kondakova; Ekaterina A Nikolaeva; Inessa D Fedoniuk; Svetlana V Mikhailova; Anna Y Krasnenko; Ivan F Stetsenko; Nikolay A Plotnikov; Olesia I Klimchuk; Yaroslav V Popov; Ekaterina I Surkova; Peter A Shatalov; Alexander S Rakitko; Valery V Ilinsky
Journal:  Mol Genet Genomic Med       Date:  2020-05-15       Impact factor: 2.473

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.